Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Cardiovascular Pharmacology and Therapeutics

• Publication date

  2013-09-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1074248413497534PMID 24064010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Symptom onset and treatment in acute myocardial infarction

  2014cited by this paper
• Relation Between Time of Symptom Onset of ST‐Segment Elevation Myocardial Infarction and Patient Baseline Characteristics: From the National Cardiovascular Data Registry

  2013cited by this paper
• Comparative Pharmacokinetics and Pharmacodynamics of Platelet Adenosine Diphosphate Receptor Antagonists and their Clinical Implications

  2012cited by this paper
• Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction

  2012cited by this paper
• Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.

  2011cited by this paper
• Stent thrombosis.

  2010cited by this paper
• Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.

  2009cited by this paper
• Stent Thrombosis in Sweden: A Report From the Swedish Coronary Angiography and Angioplasty Registry

  2009cited by this paper
• A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation.

  2007cited by this paper
• Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents

  2007cited by this paper
• Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions

  2007cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents

  2006cited by this paper
• Circadian variation in symptomatic subacute stent thrombosis after bare metal coronary stent implantation.

  2006cited by this paper
• Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).

  2006cited by this paper
• Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

  2005cited by this paper
• Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era.

  2005cited by this paper
• Findings of intravascular ultrasound during acute stent thrombosis

  2004cited by this paper
• From megakaryocytes to platelets: platelet morphogenesis takes place in the bloodstream

  1998cited by this paper
• Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men.

  1992cited by this paper
• Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.

  1990cited by this paper
• Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.

  1989cited by this paper
• Morning increase in platelet aggregability. Association with assumption of the upright posture.

  1988cited by this paper
• Circadian variation in the frequency of onset of acute myocardial infarction.

  1985cited by this paper

• A Comprehensive Review of the Pleiotropic Effects of Ticagrelor

  2022cites this paper
• Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor

  2022cites this paper
• The effect of acetylsalicylic acid dosed at bedtime on the anti-aggregation effect in patients with coronary heart disease and arterial hypertension: A randomized, controlled trial

  2019cites this paper
• Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study

  2019cites this paper
• Circadian variation of ticagrelor-induced platelet inhibition in healthy adulty

  2018cites this paper
• Twenty-four-hour time dependency of clopidogrel effects in patients with acute coronary syndromes: The CiCAD-Study

  2018cites this paper
• Circadian Periodicity of Ischemic Heart Disease: A Systematic Review of the Literature.

  2017cites this paper
• Is platelet inhibition correlated with time from last intake on P2Y12 blockers after an acute coronary syndrome? A pilot study

  2016cites this paper
• Circadian Distribution of Ventricular Tachyarrhythmias and Association with Mortality in the MADIT‐CRT Trial

  2015cites this paper
• Clopidogrel: A multifaceted affair

  2015cites this paper
• Prevention of cardiovascular events with antiplatelet treatment: does time of intake matter for aspirin and ADP receptor blockers?

  2015cites this paper
• Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention

  2014cites this paper
• Symptom onset and treatment in acute myocardial infarction

  2014cites this paper
• Antiplatelet agents for chronic kidney disease.

  2013cites this paper